DRY EYE TEARS 0.2 %
HYPROMELLOSE : 0.2 % GLYCERINE : 0.2 % · DIN 02389886 · JUNO OTC INC
Health Canada status: MARKETED
What is DRY EYE TEARS?
DRY EYE TEARS 0.2 % contains HYPROMELLOSE : 0.2 % GLYCERINE : 0.2 %. It is listed in the Health Canada Drug Product Database under DIN 02389886, held by JUNO OTC INC, supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as marketed, status dated 04-Feb-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02389886 |
|---|---|
| Brand name | DRY EYE TEARS |
| Generic / active ingredient | HYPROMELLOSE : 0.2 % GLYCERINE : 0.2 % |
| Manufacturer | JUNO OTC INC |
| Strength | 0.2 % |
| Dosage form | SOLUTION |
| Route of administration | OPHTHALMIC |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS. |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 04-Feb-2025 |
What can be used instead?
Other Canadian products sharing ATC code S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS.. 26 of 94 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALCON TEARS 0.5% | 0.5 % | SOLUTION | ALCON CANADA INC | MARKETED | DIN 00000809 |
| ALCON TEARS 1% | 1 % | SOLUTION | ALCON CANADA INC | MARKETED | DIN 00000817 |
| AMO ENDOSOL SOLUTION | 0.17 % | SOLUTION | AMO CANADA COMPANY | MARKETED | DIN 02007967 |
| ARTIFICIAL TEARS | 0.2 % | SOLUTION | JUNO OTC INC | MARKETED | DIN 02354535 |
| LUBRICANT EYE DROPS/ ARTIFICIAL TEARS | 0.3 % | DROPS | BAUSCH & LOMB INC | MARKETED | DIN 02321696 |
| MIEBO | 100 % | SOLUTION | BAUSCH & LOMB INC | MARKETED | DIN 02551403 |
| MURINE | 6 MG | SOLUTION | PRESTIGE BRANDS INC | MARKETED | DIN 02247538 |
| PRESERVATIVE-FREE THERA TEARS LUBRICANT EYE DROPS | 0.25 % | DROPS | MEDTECH PRODUCTS INC | MARKETED | DIN 02242082 |
| REFRESH | 1.4 % | DROPS | ABBVIE CORPORATION | MARKETED | DIN 02138670 |
| REFRESH CELLUVISC | 1 % | DROPS | ABBVIE CORPORATION | MARKETED | DIN 00870153 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.